Charles E. Murry, MD, PhD, Director, Center for Cardiovascular Biology, Co-director, Institute of Stem Cell & Regenerative Medicine, Professor of Pathology and Bioengineering, University of Washington
Mengfeng Li, MD., PhD Professor of Microbiology and Molecular Medicine, Dean of Sun Yet-Sen Med School and Vice Chancellor of Sun Yte-Sen University, China
This series addresses methods of measuring medication adherence, the pros and cons of the different methods, and the methodological challenges of assessing medication adherence.
Josep M. Llovet, M.D., Ph.D., Professor, Department of Medicine, Mount Sinai School of Medicine, NY Department of Research, University of Barcelona, Spain Director, HCC Program, Mount Sinai School of Medicine, NY
Gary Silverman, MD, PhD, Professor, Department of Pediatrics, Chief, UPMC Newborn Medicine Program, Magee-Womens Hospital, Children’s Hospital of Pittsburgh of UPMC
Translating the Biophysics of Molecular Switches: Signaling Mechanisms and Inhibition of Ras and Rho GTPases
Researchers at academic institutions, government and industry including structural, computational and in vivo functional biologists as well as cell signaling investigators at all levels (graduate students, postdoctoral students, junior faculty) are invited.
Highly Penetrative Nanocarriers Loaded With Drugs Targeted to Resistant Cells Improve Treatment of Glioblastoma
W. Mark Saltzman, PhD, Giozueta Foundation, Professor of Biomedical Engineering, Chemical & Environmental Engineering & Physiology, Yale University
Nancy Fisher (Core Director, UNC) and Kelly Roney (Regulatory Project Leader, RTI)
Benjamin Deneen, PhD, Associate Professor, Dept. of Neuroscience, Center for Cell and Gene Therapy, Baylor College of Medicine